+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID07766187

Evaluating Durvalumab with Histotripsy Ultrasound Treatment for Advanced Intrahepatic Cholangiocarcinoma

Led by University of Wisconsin, Madison · Updated on 2026-10-30

12

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the addition of histotripsy, a non-invasive ultrasound treatment that destroys tumor tissue, to maintenance durvalumab therapy in people with advanced intrahepatic cholangiocarcinoma iCCA. This pilot phase II study aims to assess whether this combination increases the immune systems response and to evaluate its safety. The study also explores effects on untreated tumors and blood markers related to immune activity and tumor DNA. Participants will receive maintenance durvalumab infusions every 28 days as per standard care, with histotripsy treatment performed once on cycle 1 day 8 using an FDA-cleared focused ultrasound device. Research-specific visits include assessments before histotripsy, a biopsy 14 days after treatment, and a safety check 30 days post-treatment. Other treatments and visits are part of ongoing medical care. Participants will be followed for up to five years or until disease progression. During the study, participants will undergo biopsies and blood tests to monitor immune response and tumor activity. Researchers will track immune-related side effects and overall treatment effects using scans and laboratory tests. The main outcomes include changes in adaptive immune response and safety within 30 days after histotripsy. Long-term outcomes such as progression-free and overall survival will also be observed over five years.

CONDITIONS

Brief Title

Combination Therapy Using Durvalumab and Histotripsy for Treatment of Intrahepatic Cholangiocarcinoma

Research Team

C

Cancer Connect

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here